Alerts will be sent to your verified email
Verify Email
BOSTON BIO
|
Laser Eyecare
|
Transpact Enterprise
|
GKB Ophthalmics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-2.31 % | -15.12 % | -3.59 % |
|
5yr average Equity Multiplier
|
1.79 | 1.7 | 1.98 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.13 | 0.67 |
|
5yr Avg Net Profit Margin
|
-56.86 % | -82.06 % | -1.93 % |
|
Price to Book
|
0.84 | 15.5 | 0.58 |
|
P/E
|
0.0 | 742.09 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
5732.3 Days | 273.64 Days | 61.76 Days |
|
Inventory Days
|
54.91 Days | 592.41 Days | 179.68 Days |
|
Days Receivable
|
5457.75 Days | 218.34 Days | 90.24 Days |
|
Days Payable
|
0.0 | 56.65 Days | 195.73 Days |
|
5yr Average Interest Coverage Ratio
|
0.0 | -445.43 | 0.33 |
|
5yr Avg ROCE
|
-1.49 % | -14.65 % | 0.11 % |
|
5yr Avg Operating Profit Margin
|
-56.86 % | -58.19 % | 2.64 % |
|
5 yr average Debt to Equity
|
0.29 | 0.34 | 0.21 |
|
5yr CAGR Net Profit
|
n/a | n/a | 50.56 % |
|
5yr Average Return on Assets
|
-1.01 % | -8.72 % | -1.54 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
2.14 % | 0.13 % | 51.06 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -45.76 % | -8.1 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Laser Eyecare
|
Transpact Enterprise
|
GKB Ophthalmics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|